Related Experiment Video
Updated: Jul 2, 2026
13:08
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Factor VIIa binding to endothelial cell protein C receptor
L Vijaya Mohan Rao1, Usha R Pendurthi
1Center for Biomedical Research, The University of Texas Health Science Center, Tyler, TX, USA. vijay.rao@uthct.edu
Thrombosis Research
|August 12, 2008
Summary
Factor VIIa (FVIIa) binds to the endothelial protein C receptor (EPCR), potentially interfering with protein C activation and signaling. This interaction may also influence FVIIa clearance, impacting its physiological role.
Area of Science:
- Endothelial biology
- Coagulation cascade
- Receptor-ligand interactions
Background:
- Endothelial protein C receptor (EPCR) is crucial for protein C activation and signaling.
- Factor VIIa (FVIIa) is a key coagulation factor.
- Recent findings indicate a direct interaction between FVIIa and EPCR.
Purpose of the Study:
- To review current data on the interaction between FVIIa and EPCR.
- To discuss the physiological implications of FVIIa binding to EPCR.
- To explore the consequences for protein C activation and FVIIa clearance.
Main Methods:
- Literature review of recent studies on FVIIa-EPCR interactions.
- Analysis of binding kinetics and functional assays.
- Discussion of proposed mechanisms of interaction.
Main Results:
- FVIIa specifically binds to EPCR on endothelial cells.
- FVIIa:EPCR complex formation does not promote coagulation.
- FVIIa may compete with protein C for EPCR binding, potentially impairing protein C activation and signaling.
- FVIIa binding to EPCR might affect FVIIa clearance.
Conclusions:
- The interaction between FVIIa and EPCR has significant physiological relevance.
- This interaction may modulate endothelial protein C activation and signaling pathways.
- Further research is needed to fully elucidate the consequences of FVIIa-EPCR binding.
Related Concept Videos
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...